A detailed history of High Net Worth Advisory Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, High Net Worth Advisory Group LLC holds 11,934 shares of BMY stock, worth $702,554. This represents 0.17% of its overall portfolio holdings.

Number of Shares
11,934
Previous 11,859 0.63%
Holding current value
$702,554
Previous $492,000 25.41%
% of portfolio
0.17%
Previous 0.15%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$39.66 - $51.75 $2,974 - $3,881
75 Added 0.63%
11,934 $617,000
Q2 2024

Jul 17, 2024

SELL
$40.25 - $52.99 $168,526 - $221,869
-4,187 Reduced 26.09%
11,859 $492,000
Q1 2024

Apr 11, 2024

BUY
$47.98 - $54.4 $50,618 - $57,392
1,055 Added 7.04%
16,046 $870,000
Q4 2023

Jan 08, 2024

SELL
$48.48 - $57.85 $190,041 - $226,772
-3,920 Reduced 20.73%
14,991 $769,000
Q3 2023

Oct 05, 2023

SELL
$57.89 - $64.73 $30,681 - $34,306
-530 Reduced 2.73%
18,911 $1.1 Million
Q2 2023

Jul 07, 2023

SELL
$63.71 - $70.74 $151,629 - $168,361
-2,380 Reduced 10.91%
19,441 $1.24 Million
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $58,892 - $69,737
-860 Reduced 3.79%
21,821 $1.57 Million
Q3 2022

Oct 24, 2022

SELL
$0.13 - $76.84 $432 - $255,877
-3,330 Reduced 12.8%
22,681 $1.61 Million
Q2 2022

Aug 10, 2022

BUY
$72.62 - $79.98 $567,162 - $624,643
7,810 Added 42.91%
26,011 $2 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $122,960 - $147,440
2,000 Added 12.34%
18,201 $1.33 Million
Q4 2021

Aug 10, 2022

BUY
$53.63 - $62.52 $1,340 - $1,563
25 Added 0.15%
16,201 $1.01 Million
Q4 2021

Apr 27, 2022

BUY
$53.63 - $62.52 $867,518 - $1.01 Million
16,176 New
16,176 $1.02 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track High Net Worth Advisory Group LLC Portfolio

Follow High Net Worth Advisory Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Net Worth Advisory Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Net Worth Advisory Group LLC with notifications on news.